← DR REDDYS LABORATORIES LTD

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 TTM
Total Revenue $140.8b
$2.2b -98.45%
$2.2b +2.02%
$2.3b +4.09%
$2.6b +12.00%
$2.8b +8.94%
$3.0b +5.87%
$279.2b +9230.35%
$325.5b +16.61%
$3.6b -98.90%
$331.2b +9151.01%
Cost of Goods and Services Sold $62.5b
$1.0b -98.38%
$1.0b +0.89%
$1.1b +5.01%
$1.2b +10.85%
$1.3b +11.81%
$1.3b -2.19%
$1.4b +7.02%
$1.6b +13.99%
$1.7b +6.96%
$165.0b +9658.07%
Cost of revenues $62.5b
$65.7b +5.24%
$1.0b -98.45%
$1.1b +5.01%
$86.6b +8005.24%
$1.3b -98.47%
$1.3b -2.19%
$1.4b +7.02%
$1.6b +13.99%
$1.7b +6.96%
$165.0b +9658.07%
Cost Of Revenue — — — — — — $106.5b
$115.6b +8.47%
$135.1b +16.92%
$158.7b +17.44%
$165.0b +4.00%
Net Interest Income — — — — — — ($248.0m)
$567.0m +328.63%
($152.0m) -126.81%
($12.0m) +92.11%
($566.0m) -4616.67%
Gross Profit $78.4b
$1.2b -98.50%
$1.2b +2.90%
$1.2b +3.40%
$1.4b +12.99%
$1.5b +6.46%
$1.7b +13.00%
$2.0b +15.81%
$2.2b +13.60%
$1.9b -15.29%
$166.2b +8697.09%
Research and development — $281.0m $226.0m $204.0m $226.0m $230.0m $236.0m $274.0m $320.0m $24.1b $23.6b
Research and development expenses $19.6b $18.3b $226.0m $204.0m $16.5b $230.0m $236.0m $274.0m $320.0m $256.0m $23.6b
Selling, General and Administrative Expense — $720.0m $707.0m $665.0m $747.0m $818.0m $828.0m $926.0m $1.1b — $109.7b
Selling, general and administrative expenses $46.4b $46.9b $707.0m $665.0m $54.6b $818.0m $828.0m $926.0m $1.1b $1.1b $109.7b
Operating expenses:
Other Operating Expenses — — — — — — ($7.1b) ($1.8b) ($2.8b) ($3.7b) —
Total operating expenses $64.9b $64.4b $904.0m $1.0b $78.8b $1.1b $1.0b $1.1b $1.4b $1.4b $129.9b
Other Operating Income Expense — $12.0m $28.0m $57.0m $13.0m $36.0m $72.0m $50.0m $51.0m $58.6b —
Other Non Operating Income Expenses — — — — — — — — $11.0b $13.6b —
Interest Expense — $788.0m $889.0m $983.0m $970.0m $958.0m $1.4b $1.7b $2.8b $3.7b $4.2b
Interest Expense On Lease Liabilities — — — $230.0m $227.0m $221.0m $214.0m $256.0m $391.0m — $4.2b
Interest Income — — — — — — $1.2b $2.3b $2.7b $3.7b $3.6b
Net Non Operating Interest Income Expense — — — — — — ($248.0m) $567.0m ($152.0m) ($12.0m) ($566.0m)
Gain On Sale Of PPE — — — — — — ($1.2b) $900.0m $1.5b $2.5b $3.0b
Gain On Sale Of Security — — — — — — $3.1b $3.4b $4.9b $4.1b $4.9b
Other income, net ($1.1b) ($788.0m) ($2.0b) ($4.3b) ($982.0m) ($36.0m) ($72.0m) ($50.0m) ($51.0m) ($81.0m) $5.5b
Other Income Expense — — — — — — $1.6b $6.0b $4.9b $4.7b $5.5b
Pre-Tax Income — — — — — — $60.4b $71.9b $76.8b $54.8b $41.3b
Current Tax Expense (Income) — $1.8b $4.7b $6.6b $8.2b $6.4b $12.9b $19.5b $22.6b — —
Deferred Tax Expense (Income) — $2.8b ($1.1b) ($8.1b) $1.0b $2.3b $2.4b ($3.3b) ($3.0b) — —
Deferred Tax Expense (Income) Recognised In Profit Or Loss — ($2.9b) $1.1b $8.2b ($1.1b) ($2.2b) ($2.0b) $3.4b $3.1b — —
Tax expense, net $2.6b $4.5b $3.6b $1.5b $9.2b $115.0m $186.0m $194.0m $229.0m $132.0m —
Income Tax Expense Continuing Operations — $70.0m $53.0m ($19.0m) $125.0m $115.0m $186.0m $194.0m $229.0m — $8.6b
Net Income From Continuing And Discontinued Operation — — — — — — $45.1b $55.7b $56.5b $42.9b $33.1b
Net Income Continuous Operations — — — — — — $45.1b $55.7b $57.2b $42.5b $32.7b
Basic Earnings (Loss) Per Share $72.24 $0.91 $1.64 $1.56 $1.42 $1.87 $3.30 $4.02 $0.79 $0.55 $39.76
Diluted Earnings (Loss) Per Share $72.09 $0.91 $1.64 $1.56 $1.52 $1.87 $3.30 $4.01 $0.79 $0.55 $39.72
Basic Average Shares — — — — — — $830.2m $832.0m $833.0m $832.4m $832.8m
Diluted Average Shares — — — — — — $831.9m $833.5m $834.2m $833.3m $833.5m
Additional Financial Items
Applicable Tax Rate — $0 $0 $0 $0 $0 $0 — — — —
Average Effective Tax Rate — $0 $0 ($0) $0 $0 $0 $0 $0 $0 —
Depreciation Right of Use Assets — — — $491.0m $831.0m $858.0m $879.0m $1.1b $1.2b — $20.6b
Finance Income $1.6b $44.0m $33.0m $33.0m $36.0m $41.0m $52.0m $68.0m $88.0m $84.0m —
Impairment Loss Recognised In Profit Or Loss Goodwill — $16.3b $16.3b — — — — — — — —
Impairment Loss Recognised In Profit Or Loss Intangible Assets Other Than Goodwill — $53.0m — — — — — — — — —
Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss — — — $222.0m $117.0m $100.0m $9.0m $1.0m $20.0m — —
Profit Loss Attributable To Noncontrolling Interests — $0 — — — — — — $8.0m — —
Profit Loss Attributable To Owners Of Parent — $151.0m — — — — — — $663.0m — —
Profit Loss Before Tax — $220.0m $325.0m $239.0m $361.0m $426.0m $734.0m $862.0m $900.0m — —
Profit Loss From Operating Activities — $183.0m $302.0m $212.0m $332.0m $389.0m $695.0m $813.0m $842.0m — —
Impairment of non-current assets, net — $53.0m $210.0m $222.0m $8.6b $100.0m $9.0m $1.0m $20.0m $38.0m —
Results from operating activities (A) $13.5b $11.9b $20.9b $212.0m $24.3b $389.0m $695.0m $813.0m $842.0m $539.0m —
Finance income, net (B) $806.0m $2.1b $16.0m $1.5b $1.7b $28.0m $35.0m $48.0m $55.0m $44.0m —
Share of profit of equity accounted investees, net of tax (C) $349.0m $344.0m $438.0m $561.0m $480.0m $9.0m $5.0m $2.0m $3.0m $1.0m —
Profit before tax [(A)+(B)+(C)] $14.7b $14.3b $22.4b $18.0b $26.4b $426.0m $734.0m $862.0m $900.0m $584.0m —
Profit for the year $12.0b $9.8b $272.0m $259.0m $17.2b $311.0m $548.0m $668.0m $671.0m $452.0m —
Equity holders of the parent company — — — — — — $45.1b $55.7b $663.0m $456.0m —
Non-controlling interests — — — — — — $0 $0 $8.0m ($4.0m) —
Depreciation Amortization Depletion Income Statement — — — — — — — — $17.0b $20.6b $20.6b
Depreciation And Amortization In Income Statement — — — — — — — — $17.0b $20.6b $20.6b
Diluted EPS — — — — — — $54.17 $66.92 $67.78 $51.42 $39.72
Diluted NI Availto Com Stockholders — — — — — — $45.1b $55.7b $56.5b $42.9b $33.1b
Earnings From Equity Interest — — — — — — $370.0m $147.0m $217.0m $134.0m $140.0m
Impairment Of Capital Assets — — — — — — $699.0m $3.0m $1.7b $3.5b $3.5b
Minority Interests — — — — — — $0 $0 ($701.0m) $384.0m $389.0m
Normalized EBITDA — — — — — — $73.2b $82.6b $92.0b $74.6b $66.7b
Normalized Income — — — — — — $44.2b $51.2b $53.0b $39.3b $28.6b
Other Special Charges — — — — — — — ($1.5b) — ($1.4b) —
Reconciled Depreciation — — — — — — $12.6b $14.8b $17.1b $20.6b $20.6b
Salaries And Wages — — — — — — — — $55.8b $59.9b $59.9b
Selling General And Administration — — — — — — $68.0b $77.2b $93.9b $106.8b —
Special Income Charges — — — — — — ($1.9b) $2.4b ($171.0m) $428.0m $821.0m
Tax Effect Of Unusual Items — — — — — — $297.8m $1.3b $1.2b $1.1b $1.2b
Tax Provision — — — — — — $15.3b $16.2b $19.5b $12.4b $8.6b
Tax Rate For Calcs — $0 $0 ($0) $0 $0 $0 $0 $0 $0 $0
Write Off — — — — — $7.6b $699.0m $3.0m — — ($3.0m)
Depreciation And Amortisation Expense — $11.7b — — — — — — — — $20.6b
Employee Benefits Expense — $32.1b $33.6b $33.8b $36.3b $38.9b $46.5b $50.3b $55.8b — —
Expense From Share-Based Payment Transactions With Employees — $482.0m $474.0m $615.0m $741.0m $740.0m $644.0m $821.0m $796.0m — —
Finance Costs — $13.0m $17.0m $13.0m $13.0m $13.0m $17.0m $21.0m $33.0m — —
Finance expense ($781.0m) ($817.0m) ($17.0m) ($13.0m) ($970.0m) ($13.0m) ($17.0m) ($21.0m) ($33.0m) ($40.0m) —
Operating Expense — — — — — — $80.3b $98.3b $118.4b $127.1b $129.9b
Net Foreign Exchange Loss — $29.0m $274.0m $0 $0 — — — — — —
Total Unusual Items — — — — — — $1.2b $5.8b $4.7b $4.6b $5.7b
Total Expenses — — — — — — $186.8b $213.9b $253.5b $285.8b $294.9b

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.